Цитотоксичность апконверсионных наночастиц с оболочками. Обзор
Р. А. Верховский, Р. А. Анисимов, М. В. Ломова, Д. К. Тучина, Е. Н. Лазарева, А. А. Доронкина, А. М. Мыльников, Н. А. Наволокин, В. И. Кочубей, И. Ю. Янина

Список литературы
1.	Wang M., Abbineni G., Clevenger A., Mao C., Xu S., “Upconversion nanoparticles: Synthesis, surface modification and biological applications”, Nanomed. : Nanotechnol. Biol. Med, 7 (2011), 710–729
2.	Cao Y., Wu J., Zheng X., Lu Y., Piper J. A., Lu Y., Packer N. H., “Assessing the activity of antibodies conjugated to upconversion nanoparticles for immunolabeling”, Anal. Chim. Acta, 1209 (2022), 339863
3.	Li Y., Chen C., Liu F., Liu J., “Engineered lanthanidedoped upconversion nanoparticles for biosensing and bioimaging application”, Microchim. Acta, 189 (2022), 109
4.	Liang G., Wang H., Shi H., Wang H., Zhu M., Jing A., Li J., Li G., “Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment”, J. Nanobiotechnol., 18 (2020), 154
5.	Rafique R., Kailasa S. K., Park T. J., “Recent advances of upconversion nanoparticles in theranostics and bioimaging applications”, Trends Anal. Chem., 120:115646 (2019), 1–19
6.	Ai X., Lyu L., Zhang Y., Tang Y., Mu J., Liu F., Zhou Y., Zuo Z., Liu G., Xing B., “Remote regulation of membrane channel activity by site-specific localization of lanthanide-doped upconversion nanocrystals”, Angew. Chem. Int. Ed., 56:11 (2017), 3031–3035
7.	Sun M., Xu L., Ma W., Wu X., Kuang H., Wang L., Xu C., “Phototherapy: Hierarchical plasmonic nanorods and upconversion core-satellite nanoassemblies for multimodal imaging-guided combination phototherapy”, Adv. Mater, 28:5 (2016), 897
8.	Wang C., Tao H., Cheng L., Liu Z., “Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles”, Biomaterials, 32:26 (2011), 6145–6154
9.	Tian G., Zhang X., Gu Z., Zhao Y., “Recent advances in upconversion nanoparticles-based multifunctional nanocomposites for combined cancer therapy”, Adv. Mater., 27:47 (2015), 7692–7712
10.	Wang M., Hu C., Su Q., “Luminescent Lifetime Regulation of Lanthanide-Doped Nanoparticles for Biosensing”, Biosensors, 12:2 (2022), 131
11.	He S., Song J., Liu J., Liu L., Qu J., Cheng Z., “Enhancing Photoacoustic Intensity of Upconversion Nanoparticles by Photoswitchable Azobenzene-Containing Polymers for Dual NIR-II and Photoacoustic Imaging In Vivo”, Adv. Opt. Mater, 7 (2019), 1900045
12.	Yuan S., Liu Z., Liang T., Jin D., Wang H., Qiao R., Dong M., Gong P., “Au-decorated $NaYF_4:Yb$,$Tm@NaGdF_4:Yb@TiO_2$ nanophotosensitizers for photodynamic therapy and MR/PET imaging”, Mater. Lett, 314 (2022), 131926
13.	Ni J., Xu H., Zhong Y., Zhou Y., Hu S., “Activatable UCL/CT/MR-enhanced in vivo imaging-guided radiotherapy and photothermal therapy”, J. Mater. Chem. B, 10 (2022), 549–561
14.	Ge J., Chen L., Huang B., Gao Y., Zhou D., Zhou Y., Chen C., Wen L., Li Q., Zeng J., Zhong Z., Gao M., “Anchoring Group-Mediated Radiolabeling of Inorganic Nanoparticles - A Universal Method for Constructing Nuclear Medicine Imaging Nanoprobes”, ACS Appl. Mater. Interfaces, 14:7 (2022), 8838–8846
15.	Lisjak D., Plohl O., Ponikvar-Svet M., Majaron B., “Dissolution of upconverting fluoride nanoparticles in aqueous suspensions”, RSC Adv., 5 (2015), 27393–27397
16.	Plohl O., Kralj S., Majaron B., Fröhlich E., Ponikvar-Svet M., Makovec D., Lisjak D., “Amphiphilic coatings for the protection of upconverting nanoparticles against dissolution in aqueous media”, Dalton Trans, 46 (2017), 6975–6984
17.	Andresen E., Würth C., Prinz C., Michaelis M., ReschGenger U., “Time-resolved luminescence spectroscopy for monitoring the stability and dissolution behaviour of upconverting nanocrystals with different surface coatings”, Nanoscale, 12 (2020), 12589–12601
18.	Saleh M. I., Rьhle B., Wang S., Radnik J., You Y., Resch-Genger U., “Assessing the protective effects of different surface coatings on $NaYF_4:Yb^{3+}, Er^{3+}$ upconverting nanoparticles in buffer and DMEM”, Sci. Rep, 10 (2020), 1–11
19.	Adan A., Kiraz Y., Baran Y., “Cell Proliferation and Cytotoxicity Assays”, Curr. Pharm. Biotechnol., 17:14 (2016), 1213–1221
20.	Zhou J., Liu Z., Li F., “Upconversion nanophosphors for small-animal imaging”, Chem. Soc. Rev., 41 (2012), 1323–1349
21.	Chávez-García D., Juárez-Moreno K., Campos C. H., Tejeda E. M., Alderete J. B., Hirata G. A., “Cytotoxicity, genotoxicity and uptake detection of folic acid-functionalized green upconversion nanoparticles $Y_2O_3/Er^{3+}, Yb^{3+}$ as biolabels for cancer cells”, J. Mater. Sci., 53:9 (2018), 6665–6680
22.	Chavez D. H., Juarez-Moreno K., Hirata G. A., “Aminosilane functionalization and cytotoxicity effects of upconversion nanoparticles $Y_2O_3$ and $Gd_2O_3$ CoDoped with $Yb^{3+}$ and $Er^{3+}$”, Nanobiomedicine, 3:1 (2016), 1–7
23.	Gu Y., Qiao X., Zhang J., Sun Y., Tao Y., Qiao S.- X., “Effects of surface modification of upconversion nanoparticles on cellular uptake and cytotoxicity”, Chem. Res. Chin. Univ., 32:3 (2016), 474–479
24.	Das G. K., Stark D., Kennedy I. M., “Potential Toxicity of Up-Converting Nanoparticles Encapsulated with a Bilayer Formed by Ligand Attraction”, Langmuir, 30:27 (2014), 8167–8176
25.	Atabaev T. Sh., Lee J. H., Han D. W., Hwang Y. H., Kim H. K., “Cytotoxicity and cell imaging potentials of submicron color-tunable yttria particles”, J. Biomed. Mater. Res. A., 100:9 (2012), 2287–2294
26.	Gao G., Zhang C., Zhou Z., Zhang X., Ma J., Li C., Jin W., Cui D., “One-pot hydrothermal synthesis of lanthanide ions doped one-dimensional upconversion submicrocrystals and their potential application in vivo CT imaging”, Nanoscale, 5:1 (2013), 351–362
27.	Gupta B. K., Narayanan T. N., Vithayathil S. A., Lee Y., Koshy S., Reddy A. L., Saha A., Shanker V., Singh V. N., Kaipparettu B. A., Martí A. A., Ajayan P. M., “Highly luminescent-paramagnetic nanophosphor probes for in vitro high-contrast imaging of human breast cancer cells”, Small, 8:19 (2012), 3028–3034
28.	Wang C., He M., Chen B., Hu B., “Study on cytotoxicity, cellular uptake and elimination of rare-earth-doped upconversion nanoparticles in human hepatocellular carcinoma cells”, Ecotoxicol. Environ. Saf., 203:110951 (2020), 1–10
29.	Hemmer E., Yamano T., Kishimoto H., Venkatachalam N., Hyodo H., Soga K., “Cytotoxic aspects of gadolinium oxide nanostructures for up-conversion and NIR bioimaging”, Acta Biomater., 9:1 (2013), 4734–4743
30.	Zhang J., Liu F., Li T., He X., Wang Z., “Surface charge effect on the cellular interaction and cytotoxicity of $NaYF_4:Yb^{3+}$, $Er^{3+}@SiO_2$ nanoparticles”, RSC Adv., 5 (2015), 7773–7780
31.	Bae Y. M., Park Y. I., Nam S. H., Kim J. H., Lee K., Kim H. M., Yoo B., Choi J. S., Lee K. T., Hyeon T., Suh Y. D., “Endocytosis, intracellular transport, and exocytosis of lanthanide-doped upconverting nanoparticles in single living cells”, Biomaterials, 33:35 (2012), 9080–9086
32.	Guller A., Generalova A. N., Petersen E. V., Nechaev A. V., Trusova I. A., Landyshev N. N., Nadort A., Grebenik E. A., Deyev S. M., Shekhter A. B., Zvyagin A. V., “Cytotoxicity and non-specific cellular uptake of bare and surface-modified upconversion nanoparticles in human skin cells”, Nano Res., 8:1546 (2015), 1–17
33.	Li R., Ji Z., Dong J., Chang C. H., Wang X., Sun B., Wang M., Liao Y. P., Zink J. I., Nel A. E., Xia T., “Enhancing the imaging and biosafety of upconversion nanoparticles through phosphonate coating”, ACS Nano., 9:3 (2015), 3293–3306
34.	Gnach A., Lipinski T., Bednarkiewicz A., Rybka J., Capobianco J. A., “Upconverting nanoparticles: Assessing the toxicity”, Chem. Soc. Rev., 44 (2015), 1561–1584
35.	Torresan M. F., Wolosiuk A., “Critical Aspects on the Chemical Stability of $NaYF_4$-Based Upconverting Nanoparticles for Biomedical Applications”, ACS Appl. Bio. Mater., 4:2 (2021), 1191–1210
36.	Xia A., Chen M., Gao Y., Wu D., Feng W., Li F., “$Gd^{3+}$ complex-modified $NaLuF_4$-based upconversion nanophosphors for trimodality imaging of NIR-toNIR upconversion luminescence, X-Ray computed tomography and magnetic resonance”, Biomaterials, 33:21 (2012), 5394–5405
37.	Abdul Jalil R., Zhang Y., “Biocompatibility of silica coated NaYF(4) upconversion fluorescent nanocrystals”, Biomaterials, 29:30 (2008), 4122–4128
38.	Guo H., Hao R., Qian H., Sun S., Sun D., Yin H., Liu Z., Liu X., “Upconversion nanoparticles modified with aminosilanes as carriers of DNA vaccine for foot-and-mouth disease”, Appl Microbiol Biotechnol., 95:5 (2012), 1253–1263
39.	Li C., Yang D., Ma P., Chen Y., Wu Y., Hou Z., Dai Y., Zhao J., Sui C., Lin J., “Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery”, Small, 9:24 (2013), 4150–4159
40.	Ma J., Huang P., He M., Pan L., Zhou Z., Feng L., Gao G., Cui D., “Folic acid-conjugated $LaF_3:Yb,Tm@SiO_2$ nanoprobes for targeting dualmodality imaging of upconversion luminescence and X-ray computed tomography”, J Phys Chem B., 116:48 (2012), 14062–14070
41.	Li X., Tang Y., Xu L., Kong X., Zhang L., Chang Y., Zhao H., Zhang H., Liu X., “Dependence between cytotoxicity and dynamic subcellular localization of upconversion nanoparticles with different surface charges”, RSC Adv., 7:53 (2017), 33502–33509
42.	Zhou N., Qiu P., Wang K., Fu H., Gao G., He R., Cui D., “Shape-controllable synthesis of hydrophilic $NaLuF_4:Yb,Er$ nanocrystals by a surfactant-assistant two-phase system”, Nanoscale Res. Lett, 8:1 (2013), 518
43.	Liu C., Shao H., Li D., Sui X., Liu N., Rahman S. U., Li X., Arany P. R., “Safety and efficacy of citric acidupconverting nanoparticles for multimodal biological imaging in BALB/c mice”, Photodiagnosis Photodyn. Ther., 36 (2021), 102485
44.	Vedunova M. V., Mishchenko T. A., Mitroshina E. V., Ponomareva N. V., Yudintsev A. V., Generalova A. N., “Cytotoxic effects of upconversion nanoparticles in primary hippocampal cultures”, RSC Adv., 6:40 (2016), 33656–33665
45.	Wang C., Cheng L., Xu H., Liu Z., “Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles”, Biomaterials, 33:19 (2012), 4872–4881
46.	Chatterjee D. K., Rufaihah A. J., Zhang Y., “Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals”, Biomaterials, 29:7 (2008), 937–943
47.	Zhao L., Kutikov A., Shen J., Duan C., Song J., Han G., “Stem cell labeling using polyethylenimine conjugated $/alpha-NaYbF_4:Tm^{3+})/CaF_2$ upconversion nanoparticles”, Theranostics, 3:4 (2013), 249–257
48.	Yang D., Dai Y., Ma P., Kang X., Cheng Z., Li C., Lin J., “One-step synthesis of small-sized and water-soluble $NaREF_4$ upconversion nanoparticles for in vitro cell imaging and drug delivery”, Chemistry, 19:8 (2013), 2685–2694
49.	Himmelstoß S. F., Hirsch T., “Long-Term Colloidal and Chemical Stability in Aqueous Media of $NaYF_4$-Type Upconversion Nanoparticles Modified by Ligand-Exchange”, Part. Part. Syst. Charact, 36:10 (2019), 1900235
50.	Kembuan C., Oliveira H., Graf C., “Effect of different silica coatings on the toxicity of upconversion nanoparticles on RAW 264.7 macrophage cells”, Beilstein J. Nanotechnol., 12 (2021), 35–48
51.	Chithrani B. D., Ghazani A. A., Chan W. C. W., “Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells”, Nano Lett, 6 (2006), 662–668
52.	Chen G., Ohulchanskyy T. Y., Kumar R., Ågren H., Prasad P. N., “Ultrasmall monodisperse $NaYF_4:Yb^{3+}/Tm^{3+}$ nanocrystals with enhanced near-infrared to near-infrared upconversion photoluminescence”, ACS Nano, 4 (2010), 3163–3168
53.	Bastos V., Oskoei P., Andresen E., Saleh M. I., Rühle B., Resch-Genger U., Oliveira H. S., “Stability, dissolution, and cytotoxicity of $NaYF_4$-upconversion nanoparticles with different coatings”, Sci. Rep., 12:1 (2022), 3770
54.	Yang D., Dai Y., Liu J., Zhou Y., Chen Y., Li C., Ma P., Lin J., “Ultra-small $BaGdF_5$-based upconversion nanoparticles as drug carriers and multimodal imaging probes”, Biomaterials, 35:6 (2014), 2011–2023
55.	Полуконова Н. В., Исаев Д. С., Мыльников А. М., Бучарская А. Б., Полуконова А. В., Мудрак Д. А., Наволокин Н. А., “Оценка эффективности противоопухолевого воздействия и индукции апоптоза в клетках карциномы почки человека биологически активными добавками, содержащими ресвератрол, индол-3-карбинол и кордицепин, флуоресцентными методами визуализации”, Оптика и спектроскопия, 129:6 (2021), 727–735
56.	Мыльников А. М., Полуконова Н. В., Исаев Д. С., Дорошенко А. А., Верховский Р. А., Николаева Н. А., Мудрак Д. А., Наволокин Н. А., “Выявление путей гибели клеток карциномы почки человека А498 под действием экстракта аврана лекарственного и флавоноидов зеленого чая с помощью флуоресцентных методов визуализации”, Оптика и спектроскопия, 128:7 (2020), 964–971
57.	Сагайдачная Е. А., Янина И. Ю., Кочубей В. И., “Перспективы применения апконверсионных частиц $NaYF_4:Er,Yb$ для фототерапии”, Известия Саратовского университета. Новая серия. Серия : Физика, 18:4 (2018), 253–274